...
首页> 外文期刊>Molecular medicine reports >TIMP-3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP-2 and MMP-9 activity, and reduced TNF- expression
【24h】

TIMP-3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP-2 and MMP-9 activity, and reduced TNF- expression

机译:TIMP-3通过降低的MMP-2和MMP-9活性抑制来自动脉粥样硬化AAA的主动脉颈的SMC的增殖和迁移,并降低了TNF表达

获取原文
获取原文并翻译 | 示例
           

摘要

The present study investigated the role of tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) in regulating the proliferation, migration, apoptosis and activity of matrix metalloproteinase (MMP)-2 and -9, during the development of an atherosclerotic abdominal artery aneurysm (AAA). Experiments were conducted using rabbit AAA neck (NA) smooth muscle cells (SMCs), to investigate the potential for TIMP-3 to be used as a novel stent coating in preventing aortic dilation adjacent to the AAA. The atherosclerotic AAA model was induced in New Zealand white rabbits via a 6-week high-cholesterol diet, followed by incubation of the targeted aortic region with elastase. SMCs were isolated from the aorta adjacent to the aneurysm 30 days after AAA model induction, and stimulated with 3, 10, 30 or 100 ng/ml TIMP-3. Cell proliferation was investigated using Cell Counting Kit-8 reagent, migration was examined using a Boyden chamber assay and apoptotic rate was analyzed using the Annexin V-fluorescein isothiocyanate Apoptosis Detection kit. Gelatin zymography and ELISA were used to measure the activity of MMP-2 and MMP-9, and the expression of tumor necrosis factor- (TNF-), respectively. Analysis of cell proliferation indicated that 10, 30 and 100 ng/ml TIMP-3 reduced cell viability. Cell migration was decreased by 10, 30 and 100 ng/ml TIMP-3. MMP-2 activity was inhibited by 10, 30 and 100 ng/ml TIMP-3, and MMP-9 activity was suppressed by 30 and 100 ng/ml TIMP-3. The protein levels of secreted TNF- were reduced by 10, 30 and 100 ng/ml TIMP-3. The present study demonstrated the ability of 30 and 100 ng/ml TIMP-3 to attenuate migration and proliferation, and to inhibit the activity of MMP-2, MMP-9 and TNF- secretion of NA SMCs. In conclusion, TIMP-3 may be considered a potential therapeutic drug for use in a novel drug-eluting stent, to attenuate the progressive dilation of the aortic NA.
机译:本研究研究了基质金属蛋白酶-3(TIMP-3)组织抑制剂在动脉粥样硬化腹动脉动脉瘤的发育过程中调节基质金属蛋白酶(MMP)-2和-9的增殖,迁移,凋亡和活性的作用(AAA)。使用兔AAA颈部(NA)平滑肌细胞(SMC)进行实验,研究TIMP-3的电位用作预防AAA附近的主动脉扩张的新型支架涂层。通过6周高胆固醇饮食在新西兰白兔诱导动脉粥样硬化AAA模型,然后用弹性蛋白酶培养靶向主动脉瘤。在AAA模型诱导后30天与动脉瘤30天相邻的主动脉分离SMC,并用3,10,30或100ng / mL TIMP-3刺激。使用细胞计数试剂盒-8试剂研究细胞增殖,使用Boyden室测定检查迁移,并使用膜蛋白V-荧光素异硫氰酸酯凋亡检测试剂盒分析凋亡率。 Gelatin酶谱和ELISA用于测量MMP-2和MMP-9的活性,以及​​肿瘤坏死因子 - (TNF-)的表达。细胞增殖分析表明,10,30和100ng / mL TIMP-3降低细胞活力。细胞迁移减少10,30和100ng / ml TIMP-3。 MMP-2活性抑制10,30和100ng / mL TIMP-3,并抑制MMP-9活性30和100ng / mL TIMP-3。分泌的TNF-蛋白质水平降低10,30和100ng / mL TIMP-3。本研究证明了30和100ng / ml TIMP-3的能力,以抑制迁移和增殖,并抑制NA SMC的MMP-2,MMP-9和TNF分泌的活性。总之,TIMP-3可以被认为是用于新型药物洗脱支架的潜在治疗药物,以衰减主动脉NA的逐渐扩张。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号